ArticleJournal of virology2021

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.

Mathieu Ferrari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.